Акции медицинских устройств, включая IDEXX Laboratories и STERIS PLC, демонстрируют бычий тренд и формируют модель «чашка с ручкой»
В ноябре сектор здравоохранения показал наилучшие результаты, индекс S&P 500 в этом секторе вырос на 9,1%.
IDEXX Laboratories
Precio: 557.91Empresa y modelo de negocio
IDEXX Laboratories is a global leader in veterinary diagnostics and software solutions. The company develops and manufactures a range of products for animal health, including diagnostic tests, instruments, and software for veterinary practices. Its major business segments include Companion Animal Group, Livestock, and Poultry, with the primary revenue source coming from diagnostic products and services for pets and livestock. IDEXX also offers water testing solutions and diagnostic products for dairy and poultry industries.
Perfil de inversión
The investment profile of IDEXX Laboratories is more aligned with growth investors, given its focus on innovation and expansion in the veterinary diagnostics market. The company has shown consistent revenue growth, although it faces higher risk factors. Investors seeking a balanced approach may find it suitable, but the absence of dividends may deter those focused on income.
Métricas fundamentales
- EPS (TTM) — ganancias por acción de los últimos 12 meses, $
- 13.67 OK
- Ingresos QoQ — crecimiento trimestral de ingresos
- 4.6% ↑
- Sorpresa EPS
- 1.8% en línea
- Volatilidad 20d
- 1.9% estable
Datos FMP / FinFeed actualizados:
2026-06-06
Recomendación: Vender
Potencial: 43
Riesgo: 69
Actualizado: 2026-06-11 05:21
Cómo funciona la recomendación
Por qué la IA piensa así:
Weak momentum and high risk; hold for now.
Seguir en portafolio
Gráfico de precio
Recomendación IA
Pronóstico de analista
Evento de calendario
Señal positiva
Señal negativa
Neutral / actualización
Mantener / informativo
B My buy
S My sell
Cambios de recomendación IA
| Fecha | Antes | Después | Razón |
|---|---|---|---|
| 2026-06-03 02:43 | Mantener | Vender | Weak momentum and high risk overshadow potential upside. |
| 2026-05-24 02:41 | Vender | Mantener | Weak momentum and high risk; cautious outlook advised. |
| 2026-05-08 15:08 | — | Vender | Weak fundamentals and negative momentum raise concerns. |
Pronósticos de analistas
| Fecha | Analista | Acción | Objetivo | Precio entonces |
|---|---|---|---|---|
| 2026-04-28 12:16 | UBS | Objetivo reducido | 730 → 640 | 569.167 |
| 2026-02-09 11:54 | Piper Sandler | Objetivo reducido | 775 → 750 | 644.61 |
| 2026-02-05 10:41 | Barclays | Objetivo reducido | 850 → 800 | 642.94 |